As an overexpression of neurotrypsin-resistant agrin in neurotrypsin knock-out mice could not prevent signs of neuromuscular degeneration at old age, only the subgroup of 30–40% sarcopenia patients with neurotrypsin dependent sarcopenia [22] might be a target. Here, AGRN is linked to sarcopenia.